| P50 | author | M Francesca Cordeiro | Q62138580 |
| P2093 | author name string | Li Guo | |
| | Vy Luong | |
| | Benjamin M Davis | |
| | Joana Galvao | |
| | Nivedita Ravindran | |
| | Nasrin Haamedi | |
| | Elena Fico | |
| | Ehtesham Shamsher | |
| | Neel Kapoor | |
| P2860 | cites work | The number of people with glaucoma worldwide in 2010 and 2020 | Q24679554 |
| | Targeting amyloid-beta in glaucoma treatment. | Q24681763 |
| | Current perspective of neuroprotection and glaucoma | Q26774852 |
| | Nerve Growth Factor: A Focus on Neuroscience and Therapy | Q26786398 |
| | Glia-neuron interactions in the mammalian retina | Q26827435 |
| | Glaucoma: the retina and beyond | Q28077518 |
| | Reduced NGF level and TrkA protein and TrkA gene expression in the optic nerve of rats with experimentally induced glaucoma | Q28565007 |
| | Inhibition of p75(NTR) in glia potentiates TrkA-mediated survival of injured retinal ganglion cells | Q28567866 |
| | Chronic and Acute Models of Retinal Neurodegeneration TrkA Activity Are Neuroprotective whereas p75NTR Activity Is Neurotoxic through a Paracrine Mechanism | Q28584166 |
| | Secondary injury mechanisms in traumatic spinal cord injury: a nugget of this multiply cascade. | Q30485076 |
| | Imaging multiple phases of neurodegeneration: a novel approach to assessing cell death in vivo | Q30498073 |
| | Real-time imaging of single nerve cell apoptosis in retinal neurodegeneration | Q30832375 |
| | Assessment of rat and mouse RGC apoptosis imaging in vivo with different scanning laser ophthalmoscopes | Q33304015 |
| | Assessment of neuroprotection in the retina with DARC. | Q33377667 |
| | Network analysis of human glaucomatous optic nerve head astrocytes. | Q33442021 |
| | Safety and pharmacokinetics of escalating doses of human recombinant nerve growth factor eye drops in a double-masked, randomized clinical trial | Q33646680 |
| | Real-time imaging of single neuronal cell apoptosis in patients with glaucoma. | Q33729892 |
| | The optic nerve head in glaucoma: role of astrocytes in tissue remodeling | Q33882462 |
| | The nerve growth factor signaling and its potential as therapeutic target for glaucoma | Q34182180 |
| | Secondary post-geniculate involvement in Leber's hereditary optic neuropathy | Q34500034 |
| | Direct optic nerve sheath (DONS) application of Schwann cells prolongs retinal ganglion cell survival in vivo | Q34541548 |
| | Expression and activation of STAT3 in the astrocytes of optic nerve in a rat model of transient intraocular hypertension | Q34576887 |
| | Secondary retinal ganglion cell death and the neuroprotective effects of the calcium channel blocker lomerizine | Q34983365 |
| | Axoplasmic reticulum Ca(2+) release causes secondary degeneration of spinal axons | Q35084174 |
| | Neurofilament proteins in axonal regeneration and neurodegenerative diseases | Q35139324 |
| | Real-time imaging of retinal cell apoptosis by confocal scanning laser ophthalmoscopy | Q35457695 |
| | The role of excitotoxicity in secondary mechanisms of spinal cord injury: a review with an emphasis on the implications for white matter degeneration | Q35836498 |
| | Nerve growth factor prevents both neuroretinal programmed cell death and capillary pathology in experimental diabetes | Q36437521 |
| | NGF eye-drops topical administration in patients with retinitis pigmentosa, a pilot study | Q36447300 |
| | Morphology of astrocytes in a glaucomatous optic nerve | Q36587662 |
| | Clinical approach to optic neuropathies. | Q37239284 |
| | Experimental and clinical evidence of neuroprotection by nerve growth factor eye drops: Implications for glaucoma | Q37304132 |
| | Complications of intravitreal injections | Q37726939 |
| | Neuroprotection in glaucoma – Is there a future role? | Q37783712 |
| | The molecular basis of retinal ganglion cell death in glaucoma | Q37966513 |
| | Nerve growth factor therapy for corneal disease. | Q38006352 |
| | Stem cell-based treatments for spinal cord injury | Q38062995 |
| | GDNF, NGF and BDNF as therapeutic options for neurodegeneration. | Q38076581 |
| | Imaging of retinal ganglion cells in glaucoma: pitfalls and challenges | Q38091322 |
| | Optic neuropathies: characteristic features and mechanisms of retinal ganglion cell loss. | Q38101226 |
| | Nerve growth factor modulation of retinal ganglion cell physiology | Q38185629 |
| | Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. | Q38224185 |
| | Mechanisms of secondary degeneration after partial optic nerve transection | Q38248005 |
| | The mosaic of nerve cells in the mammalian retina | Q39193004 |
| | The nerve growth factor 35 years later | Q39667849 |
| | Expression of NGF receptor and NGF receptor mRNA in the developing and adult rat retina | Q41693227 |
| | Assessment of neuroprotective effects of glutamate modulation on glaucoma-related retinal ganglion cell apoptosis in vivo | Q42096215 |
| | Towards maximising information extraction from rodent models of ocular disease. | Q42136792 |
| | Automatic quantitative analysis of experimental primary and secondary retinal neurodegeneration: implications for optic neuropathies | Q42368091 |
| | Structural basis of glaucoma: the fortified astrocytes of the optic nerve head are the target of raised intraocular pressure | Q42495009 |
| | Nerve growth factor (NGF)-induced calcium influx and intracellular calcium mobilization in 3T3 cells expressing NGF receptors | Q42811265 |
| | Nerve growth factor eye drops improve visual acuity and electrofunctional activity in age-related macular degeneration: a case report. | Q43198410 |
| | Early events of secondary degeneration after partial optic nerve transection: an immunohistochemical study | Q43255973 |
| | Cytoarchitecture of the retinal ganglion cells in the rat. | Q43898136 |
| | Retinal ganglion cell response to axotomy and nerve growth factor antiserum in the regenerating visual system of the newt (Notophthalmus viridescens): An ultrastructural morphometric analysis | Q44037960 |
| | Nerve growth factor protects against 6-hydroxydopamine-induced oxidative stress by increasing expression of heme oxygenase-1 in a phosphatidylinositol 3-kinase-dependent manner | Q44310050 |
| | Iganidipine, a new water-soluble Ca2+ antagonist: ocular and periocular penetration after instillation | Q44324746 |
| | A model to study differences between primary and secondary degeneration of retinal ganglion cells in rats by partial optic nerve transection. | Q44526862 |
| | Inflammation-mediated retinal edema in the rabbit is inhibited by topical nepafenac | Q44667636 |
| | Pharmacokinetics of insulin uptake by ocular tissues and the role of cerebrospinal fluid in optic nerve insulin accumulation following topical insulin application | Q44825863 |
| | Brn3a as a marker of retinal ganglion cells: qualitative and quantitative time course studies in naive and optic nerve-injured retinas. | Q46098774 |
| | NGF protects endothelial cells from indomethacin-induced injury through activation of mitochondria and upregulation of IGF-1. | Q46114135 |
| | Retinal p75 and bax overexpression is associated with retinal ganglion cells apoptosis in a rat model of glaucoma | Q46408620 |
| | Pharmacokinetics of conjunctivally applied nerve growth factor in the retina and optic nerve of adult rats | Q46722460 |
| | Reactive species and oxidative stress in optic nerve vulnerable to secondary degeneration. | Q46879402 |
| | Peripheral immune cells infiltrate into sites of secondary neurodegeneration after ischemic stroke | Q48112851 |
| | Rat retinal microglial cells under normal conditions, after optic nerve section, and after optic nerve section and intravitreal injection of trophic factors or macrophage inhibitory factor | Q48268120 |
| | Retrograde transport of nerve growth factor in lesioned goldfish retinal ganglion cells | Q48718986 |
| | Blindness and glaucoma: a comparison of patients progressing to blindness from glaucoma with patients maintaining vision. | Q53872892 |
| | Topical nerve growth factor as a visual rescue strategy in pediatric optic gliomas: a pilot study including electrophysiology. | Q55463289 |
| | Early in vivo changes in calcium ions, oxidative stress markers, and ion channel immunoreactivity following partial injury to the optic nerve | Q60242452 |
| | Effect of NGF on the survival of rat retinal ganglion cells following optic nerve section | Q69059873 |
| | Nerve growth factor reduces apoptosis of axotomized retinal ganglion cells in the neonatal rat | Q71684788 |
| | Nerve growth factor promotes functional recovery of retinal ganglion cells after ischemia | Q72569221 |
| | Nerve growth factor (NGF) reduces and NGF antibody exacerbates retinal damage induced in rabbit by experimental ocular hypertension | Q74080070 |
| | Periocular accumulation of timolol and betaxolol in glaucoma patients under long-term therapy | Q78030192 |
| | Ocular application of nerve growth factor protects degenerating retinal ganglion cells in a rat model of glaucoma | Q84144841 |
| | Effect of eye NGF administration on two animal models of retinal ganglion cells degeneration | Q84999322 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 1 | |
| P921 | main subject | retinal ganglion cell | Q927337 |
| P304 | page(s) | 3375 | |
| P577 | publication date | 2020-02-25 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | Topical recombinant human Nerve growth factor (rh-NGF) is neuroprotective to retinal ganglion cells by targeting secondary degeneration | |
| P478 | volume | 10 | |